The most notable companies in this group are Merck & Co (NYSE:MRK), Medtronic plc (NYSE:MDT), CVS HEALTH Corp (NYSE:CVS).
The investment seeks capital appreciation.
The fund invests primarily in equity securities (including securities convertible into, or that the investment manager expects to be exchanged for, common or preferred stock) of U.S. and foreign companies that the investment manager believes are available at market prices less than their value based on certain recognized or objective criteria (fundamental value). The equity securities in which the fund invests are primarily common stock. The fund may invest substantially and potentially up to 100% of its assets in foreign securities and participations in foreign government debt.
The average market capitalization across the Franklin Mutual Global Discovery R6 MF is 121.76B. The market cap for tickers in the group ranges from 15.63B to 322.03B. MRK holds the highest valuation in this group at 322.03B. The lowest valued company is AER at 15.63B.
The average weekly volume growth across all stocks in the Franklin Mutual Global Discovery R6 MF was -67%. For the same stocks of the MF, the average monthly volume growth was -77% and the average quarterly volume growth was -55%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 48
P/E Growth Rating: 59
Price Growth Rating: 50
SMR Rating: 55
Profit Risk Rating: 50
Seasonality Score: 18 (-100 ... +100)